CPhI report warns industry must actively drive process improvements to meet growing global demand for pharmaceuticals.

Spectrum Pharmaceuticals appoints Joseph Turgeon as president and COO.

Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.

Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.

Lilly's Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.

Rommelag continues to supply blow-fill-seal machinery, with the brand name bottelpack.

Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.

Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.

Cubist Pharmaceuticals issues voluntary nationwide recall of one lot of CUBICIN single use vials due to presence of particulate matter.

Hospira announces nationwide voluntary recall of propofol injectable emulsion, USP, and lidocaine HCI injection, USP due to visible particuluates.

Thomson Reuters names three potential drugs anticipated to bring in over $1 billion in sales through 2019.

SI Group agrees to purchase certain Albemarle assets and products.

The cleaning validation lifecycle includes assessment, development, validation, and monitoring.

BASF builds a new plant for specialty amines in Ludwigshafen, Germany.

GSK receives FDA approval of Tanzeum for adults with type 2 diabetes.

AMRI will close its DDS facility in Syracuse, NY.

EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.

Mallinckrodt will acquire Questcor to create a diversified, high-growth specialty pharmaceuticals company.

Metrohm appoints Edward Colihan as president and CEO of Metrohm USA.

EMA sends its results on Roche investigation of pharmacovigilance non-compliance to the European Commission.

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

ThioBridge linker technology to attach different payloads to a range of antibodies

Ian Read, chairman and CEO of Pfizer, is elected chairman of the PhRMA.

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

Aesica's consortium project receives grant to investigate an industrial biotechnology process to improve the manufacturing of an API.

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Fette Compacting America appoints Sean Scully as its new president.

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.